Cargando…
An evaluation of circulating activated TAFI in septic DIC: a case series and review of the literature
BACKGROUND: Administration of recombinant human soluble thrombomodulin (rTM) is often used in Japan to treat septic disseminated intravascular coagulation (DIC). Thrombin-activatable fibrinolysis inhibitor (TAFI) is a fibrinolysis inhibitor activated by the thrombin-thrombomodulin complex, however,...
Autores principales: | Totoki, Takaaki, Ito, Takashi, Kakuuchi, Midori, Yashima, Nozomi, Maruyama, Ikuro, Kakihana, Yasuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819972/ https://www.ncbi.nlm.nih.gov/pubmed/35130927 http://dx.doi.org/10.1186/s12959-022-00364-4 |
Ejemplares similares
-
Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation
por: Ito, Takashi, et al.
Publicado: (2021) -
Leukocyte-derived extracellular DNA contributes to abnormal pressure elevation in the extracorporeal circulation circuit
por: Yashima, Nozomi, et al.
Publicado: (2020) -
Recombinant Thrombomodulin Suppresses Histone-Induced Neutrophil Extracellular Trap Formation
por: Shrestha, Binita, et al.
Publicado: (2019) -
Serum histone H3 levels and platelet counts are potential markers for coagulopathy with high risk of death in septic patients: a single-center observational study
por: Ito, Takashi, et al.
Publicado: (2019) -
Differential Regulation of Damage-Associated Molecular Pattern Release in a Mouse Model of Skeletal Muscle Ischemia/Reperfusion Injury
por: Furubeppu, Hiroaki, et al.
Publicado: (2021)